CRISPR Breakthrough: Gerbera Daisies Genetically Edited for Powdery Mildew Resistance
Athens, GA – In a significant advancement for ornamental horticulture, researchers at the University of Georgia (UGA), led by Dr. Dayton Wilde and supported by the American Floral Endowment (AFE), have successfully utilized CRISPR gene editing technology to develop gerbera daisies exhibiting resistance to powdery mildew. This achievement marks the first reported instance of CRISPR-based gene editing in gerbera, a prominent ornamental crop frequently afflicted by this economically damaging disease.
The Challenge of Powdery Mildew in Gerbera Production
Powdery mildew poses one of the most substantial threats to gerbera growers, necessitating extensive fungicide applications to maintain crop quality and market viability. Traditional breeding methods for disease resistance are often protracted and challenging to implement in existing, commercially valuable cultivars. Furthermore, transgenic approaches frequently encounter regulatory complexities. The CRISPR-based research conducted at UGA offers a promising and efficient pathway for developing non-transgenic, disease-resistant gerbera cultivars.
Methodology and Key Findings
The research team initially focused on establishing robust tissue culture and transformation systems for gerbera, which was crucial for demonstrating the feasibility of CRISPR gene editing in the crop. Subsequently, they targeted MLO genes, known to mediate plant susceptibility to powdery mildew infection. CRISPR/Cas9 constructs were designed to disrupt these genes, aiming to confer resistance. Transgenic gerbera lines incorporating these CRISPR constructs are currently undergoing evaluation to confirm successful gene mutations and assess their resistance to powdery mildew.
- 2022: Research project initiated at the University of Georgia, led by Dr. Dayton Wilde, with support from the American Floral Endowment.
- 2023: Optimized tissue culture and transformation protocols were established for multiple gerbera cultivars.
- 2024: Successful demonstration of CRISPR-based gene editing in gerbera by targeting a model gene, marking the first reported use of this technology in the crop.
- 2025: Efforts to develop powdery mildew-resistant gerbera lines by targeting MLO genes commenced, with ongoing selection and characterization of edited plants.
Impact and Future Directions
Dr. Dayton Wilde, the lead researcher, emphasized the significance of this work: “This research lays the groundwork for developing non-transgenic, gene-edited gerbera cultivars with improved disease resistance. CRISPR technology offers the potential to introduce precise mutations without incorporating foreign DNA, which may reduce regulatory barriers and accelerate commercialization.”
The ongoing selection and characterization of the CRISPR-edited gerbera lines will focus on confirming the intended mutations and thoroughly evaluating their resistance to powdery mildew. Future research endeavors may explore emerging tools such as morphogenic regulators and alternative CRISPR delivery systems to further enhance the efficiency of gene editing in gerbera.
A Step Towards Sustainable Floriculture
This project represents a crucial step towards implementing sustainable disease management strategies and the long-term improvement of ornamental crops like gerbera daisies. By supporting early-stage, high-impact research, the American Floral Endowment empowers scientists to explore innovative technologies such as CRISPR gene editing, which hold immense potential for addressing persistent production challenges within the floriculture industry.
Source: https://nationaltoday.com/us/ga/athens/news/2026/03/29/researchers-develop-crispr-edited-powdery-mildew-resistant-gerbera-daisies/
